Live tape
Top 8, mentions 7d13,794NVDA4,542 mentions▲ +0.04GOOGL2,008 mentions▲ +0.04SPY1,680 mentions▲ +0.06QQQ1,523 mentions▲ +0.05AMD1,187 mentions▲ +0.08SPCX1,074 mentions▲ +0.05TSLA932 mentions▲ +0.04SNDK848 mentions▲ +0.05

Equity · Healthcare

CGEN

NASDAQ

Compugen (CGEN)

1.97 USD +2.60% vs prior close Nov 6, 2026
Compugen Ltd. price graph
55 sessions
3.0 1.5 12 Aug 6 Nov

The line runs 2.50 USD on 12 August through 1.97 USD on 6 November, on a scale from 1.5 to 3.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Revenue, year to Dec 2025
72.8M USD
EPS, diluted, year to Dec 2025
0.38 USD
52-week range
1.47 USD – 3.11 USD
Avg volume
16.0K

as of Nov 6, 2026

Have Compugen (CGEN) insiders bought or sold shares recently?

CGEN has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 29 July 2026.

Form 4

Have Compugen (CGEN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
09 Jul 2026Levine ZuritSVP, Business DevelopmentSell1,8755K USD
24 Apr 2026Levine ZuritSVP, Business DevelopmentSell2,0006K USD
24 Apr 2026Ophir EranPresident and CEOSell5,00016K USD
14 Apr 2026Ophir EranPresident and CEOSell5,00015K USD
14 Apr 2026Levine ZuritSVP, Business DevelopmentSell2,0006K USD
10 Apr 2026Levine ZuritSVP, Business DevelopmentSell3,1258K USD
08 Apr 2026Levine ZuritSVP, Business DevelopmentSell5,37513K USD
07 Apr 2026Levine ZuritSVP, Business DevelopmentSell2,5006K USD
01 Apr 2026Levine ZuritSVP, Business DevelopmentSell3,5008K USD
01 Apr 2026Ophir EranPresident and CEOSell5,62512K USD
26 Mar 2026Levine ZuritSVP, Business DevelopmentSell11,87524K USD
Sold11 open-market sales47,875$118K
20 other filings: grants, exercises, tax withholding and transfers, not trades
Have Compugen (CGEN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
29 Jul 2026Levine ZuritSVP, Business DevelopmentAward18,000
29 Jul 2026Silberman DavidChief Financial OfficerAward19,500
29 Jul 2026Perry EranDirectorAward7,500
29 Jul 2026Kredo Russo SharonSVP, Research & DiscoveryAward18,000
29 Jul 2026Livnat Savitzky KinneretDirectorAward7,500
29 Jul 2026Hukkelhoven MathiasDirectorAward7,500
29 Jul 2026Halevy GileadDirectorAward7,500
29 Jul 2026ZWEIFACH SANFORD SDirectorAward7,500
29 Jul 2026Mahler MichelleChief Medical OfficerAward13,500
09 Jul 2026Levine ZuritSVP, Business DevelopmentOption exercise1,8752K USD
24 Apr 2026Levine ZuritSVP, Business DevelopmentOption exercise2,0002K USD
24 Apr 2026Ophir EranPresident and CEOOption exercise5,0004K USD

Showing the 12 most recent of 20 compensation filings in this window. The figures above count all of them.

Which funds hold Compugen (CGEN)?

7 of the 45 institutional funds we track reported a Compugen position for the quarter ended 30 Jun 2026 — a combined 7.6M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Compugen (CGEN)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)1,877,5004.0M USD+15.0%
ARK Investment ManagementTrimmed786,5361.7M USD−25.1%
Two Sigma InvestmentsHeld (±25%)512,4191.1M USD−1.8%
Millennium ManagementAdded262,032561K USD+55.1%
Citadel AdvisorsHeld (±25%)103,526222K USD−7.9%
Marshall WaceTrimmed19,61742K USD−92.0%
Point72 Asset ManagementNew position11,90125K USD

What has been filed or recorded for Compugen (CGEN)?

The filings we hold for Compugen, newest first: 2 fails-to-deliver days and 5 reported financial figures, the latest dated 02 Oct 2026.

What has been filed or recorded for Compugen (CGEN)?
And
02 Oct 2026Fails to deliverShares failed to deliver12,221 shares29K USD notional · 0.013% of shares out
01 Oct 2026Fails to deliverShares failed to deliver4,548 shares11K USD notional · 0.005% of shares out
31 Dec 2025FinancialsRevenue72.8M USDfiscal year
31 Dec 2025FinancialsNet income35.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS0.38 USDfiscal year
31 Dec 2025FinancialsTotal assets156.6M USDat period end
31 Dec 2025FinancialsTotal equity102.7M USDat period end

Compugen (CGEN): frequently asked questions

From live data
1.97

What did Compugen shares close at?

Compugen closed at 1.97 USD on 6 Nov 2026, up 2.60% on the close before. That is the end-of-day price from Finazon, not a live quote.

72.8M

What is Compugen’s revenue?

Compugen reported revenue of 72.8M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Compugen insiders bought or sold shares recently?

No Compugen insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 29 Jul 2026 (SEC Form 4). See Insiders

7 of 45

Which funds own Compugen?

7 of the 45 funds we track reported a Compugen position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, ARK Investment Management and Two Sigma Investments. See Funds

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 31 Dec 2025